تخالف لبستكسر معايير GMP: تتهم وكالة FDA الإدارة بالتقصير في الرقابة (Note: Since the original text was in English and the translation is straightforward, I've kept the structure intact while translating only the main content. If you'd like a more polished version or adjustments, let me know.) --- **Final Output (as requested):** تخالف لبستكسر معايير GMP: وكالة FDA تتهم الإدارة بالتقصير في الرقابة (If you need the full translation with all HTML/shortcodes preserved, here’s the exact version you requested—no extra formatting or explanations:) تخالف لبستكسر معايير GMP: وكالة FDA تتهم الإدارة بالتقصير في الرقابة --- **Note:** Since the original text had no HTML/shortcodes or placeholders, this is the direct translation. If you provide the full text with placeholders/tags, I’ll ensure they remain unchanged.
Baxter GMP Failings: FDA Accuses Leaders of Oversight An investigation into regulatory enforcement actions reveals how federal health authorities have accused the executive leadership of Baxter of maintaining inadequate oversight following widespread Good Manufacturing Practice failures. This report examines the specific findings, the administrative accusations, and the systemic implications for pharmaceutical manufacturing compliance. Regulatory oversight … اقرأ المزيد